Engineering HIV-Specific Immunity With Chimeric Antigen Receptors

AIDS Patient Care and STDs - United States
doi 10.1089/apc.2016.0239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Engineering HIV-Resistant, Anti-Hiv Chimeric Antigen Receptor T Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2017English

The Other Face of Chimeric Antigen Receptors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Systematic Testing and Specificity Mapping of Alloantigen-Specific Chimeric Antigen Receptors in T Regulatory Cells

JCI insight
Medicine
2019English

A Fast and Sensitive Luciferase-Based Assay for Antibody Engineering and Design of Chimeric Antigen Receptors

Scientific Reports
Multidisciplinary
2020English

Author Correction: Anti-Bcma Chimeric Antigen Receptors With Fully Human Heavy-Chain-Only Antigen Recognition Domains

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

T Cells With Two Functional Antigen-Specific Receptors.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

169. Clinically Adaptable CD19-Specific Chimeric Antigen Receptor

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

214. Design of Multifunctional Chimeric Antigen Receptors for T Cell Cancer Immunotherapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Nod2-Dependent Th2 Polarization of Antigen-Specific Immunity

Journal of Immunology
AllergyImmunology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy